(344 days)
Osteo-PIM Bone Graft Substitute is indicated for use only in the treatment of bony voids or gaps that are not intrinsic to the stability of the bony structure. It is intended to be gently packed into bony voids or gaps of the skeletal system (i.e., the extremities and pelvis), and the opening to the defect site sealed with bone wax. These defects may be surgically created osseous defects or osseous defects created from traumatic or degenerative injury to the bone. Subsequent to implantation, Osteo-PTM Bone Graft Substitute is resorbed and replaced with bone during the healing process.
Osteo-PTM Bone Graft Substitute is a radiolucent bone void filler composed of a porous, osteoconductive polymeric carbohydrate with a trabecular structure simulating the multidimensional interconnectivity of human cancellous bone. When placed in direct contact with host bone, Osteo-PTM supports and guides the ingrowth of new bone across the graft site and is resorbed as the healing process occurs. The consistency of Osteo-P™ allows the surgeon to easily manipulate and maximize the direct contact with viable host bone. It is intended for single patient use only and is provided sterile in single-use double sterile packaging. Osteo-P™ is available in various forms to include granules, sheets, cubes, wedges, and cylinders.
The provided text is a 510(k) Premarket Notification from the FDA for a medical device called "Osteo-PTM Bone Graft Substitute." This type of document is a regulatory submission for a medical device and describes its characteristics and comparisons to existing devices, usually for the purpose of demonstrating substantial equivalence.
However, it does not describe a study that establishes acceptance criteria for an AI/ML-based medical device or proves its performance against such criteria. Instead, it outlines the characteristics and pre-clinical testing (animal studies, biocompatibility) of a bone graft substitute to demonstrate its substantial equivalence to predicate devices, which is a key part of the 510(k) pathway.
Therefore, I cannot extract the information requested for AI/ML device acceptance criteria and performance according to your prompt. The document is about a biomaterial device, not an AI/ML diagnostic or assistive device.
§ 888.3045 Resorbable calcium salt bone void filler device.
(a)
Identification. A resorbable calcium salt bone void filler device is a resorbable implant intended to fill bony voids or gaps of the extremities, spine, and pelvis that are caused by trauma or surgery and are not intrinsic to the stability of the bony structure.(b)
Classification. Class II (special controls). The special control for this device is the FDA guidance document entitled “Class II Special Controls Guidance: Resorbable Calcium Salt Bone Void Filler Device; Guidance for Industry and FDA.” See § 888.1(e) of this chapter for the availability of this guidance.